688139 海尔生物
午间休市 05-19 11:29:43
资讯
新帖
简况
【机构调研记录】工银瑞信基金调研海尔生物
证券之星 · 05-18 08:02
【机构调研记录】工银瑞信基金调研海尔生物
每周股票复盘:海尔生物(688139)股东户数减少2.58%,持股集中度上升
证券之星 · 05-10
每周股票复盘:海尔生物(688139)股东户数减少2.58%,持股集中度上升
股市必读:海尔生物(688139)股东户数1.37万户,较上期减少2.58%
证券之星 · 05-08
股市必读:海尔生物(688139)股东户数1.37万户,较上期减少2.58%
股市必读:海尔生物(688139)股东户数1.4万户,较上期增加1.48%
证券之星 · 05-06
股市必读:海尔生物(688139)股东户数1.4万户,较上期增加1.48%
每周股票复盘:海尔生物(688139)股东户数增1.48%,Q1净利降27.93%
证券之星 · 05-02
每周股票复盘:海尔生物(688139)股东户数增1.48%,Q1净利降27.93%
盈利加速改善!海尔生物一季报营收、归母净利润环比双增
证券之星 · 04-29
盈利加速改善!海尔生物一季报营收、归母净利润环比双增
每周股票复盘:海尔生物(688139)股东户数增1.48%,户均持股市值70.84万
证券之星 · 04-19
每周股票复盘:海尔生物(688139)股东户数增1.48%,户均持股市值70.84万
海尔生物新注册《低温保存箱智能控制系统V1.0.0》等5个项目的软件著作权
证券之星 · 04-18
海尔生物新注册《低温保存箱智能控制系统V1.0.0》等5个项目的软件著作权
海尔生物(688139)披露2026年员工持股计划(草案)法律意见书,4月17日股价下跌1.44%
证券之星 · 04-17
海尔生物(688139)披露2026年员工持股计划(草案)法律意见书,4月17日股价下跌1.44%
海尔生物(688139)披露2025年年度股东会会议材料,4月16日股价上涨5.0%
证券之星 · 04-16
海尔生物(688139)披露2025年年度股东会会议材料,4月16日股价上涨5.0%
海尔生物CMEF首秀AI自主实验室,打造生命科学的“AI底座”
财经网 · 04-16
海尔生物CMEF首秀AI自主实验室,打造生命科学的“AI底座”
海尔生物(688139)4月10日股东户数1.4万户,较上期增加1.48%
证券之星 · 04-15
海尔生物(688139)4月10日股东户数1.4万户,较上期增加1.48%
东海证券:给予海尔生物买入评级
证券之星 · 04-14
东海证券:给予海尔生物买入评级
【机构调研记录】鑫元基金调研海尔生物
证券之星 · 04-13
【机构调研记录】鑫元基金调研海尔生物
智启科研新范式,海尔生物以“AI+”重塑中国生命科学产业未来
证券之星 · 04-10
智启科研新范式,海尔生物以“AI+”重塑中国生命科学产业未来
每周股票复盘:海尔生物(688139)拟推2026年员工持股计划
证券之星 · 04-05
每周股票复盘:海尔生物(688139)拟推2026年员工持股计划
海尔生物(688139)披露2026年员工持股计划草案,4月3日股价下跌0.95%
证券之星 · 04-03
海尔生物(688139)披露2026年员工持股计划草案,4月3日股价下跌0.95%
海尔生物(688139)2月28日股东户数1.39万户,较上期减少2.17%
证券之星 · 03-28
海尔生物(688139)2月28日股东户数1.39万户,较上期减少2.17%
3月23日海尔生物跌5.52%,汇添富中证互联网医疗指数(LOF)A基金重仓该股
证券之星 · 03-23
3月23日海尔生物跌5.52%,汇添富中证互联网医疗指数(LOF)A基金重仓该股
每周股票复盘:海尔生物(688139)海外收入占比达36%
证券之星 · 03-22
每周股票复盘:海尔生物(688139)海外收入占比达36%
加载更多
公司概况
公司名称:
青岛海尔生物医疗股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-10-25
主营业务:
青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象,提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内,公司低温存储技术持续领先,依托制冷平台,通过持续优化制冷系统设计、温湿控制和节能技术等核心模块,在极致稳定、绿色效能方向上构筑起代际领先优势。
发行价格:
15.53
{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"海尔生物","latestPrice":33.25,"timestamp":1779161383000,"preClose":33.25,"halted":0,"volume":2189970,"delay":0,"changeRate":0,"floatShares":316000000,"shares":316000000,"eps":0.695,"marketStatus":"午间休市","change":0,"latestTime":"05-19 11:29:43","open":33.26,"high":34.04,"low":33,"amount":73416000,"amplitude":0.0313,"askPrice":33.31,"askSize":4,"bidPrice":33.25,"bidSize":26,"shortable":0,"etf":0,"ttmEps":0.695,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779166800000},"marketStatusCode":3,"adr":0,"adjPreClose":33.25,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779154200000,1779161400000],[1779166800000,1779174000000]],"highLimit":36.58,"lowLimit":29.93,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":2.36,"roa":"--","peRate":47.841727,"roe":"1.8%","epsLYR":0.8,"committee":0.300448,"marketValue":10523000000,"turnoverRate":0.0069,"status":2,"floatMarketCap":10523000000},"requestUrl":"/m/hq/s/688139","defaultTab":"news","newsList":[{"id":"2636012675","title":"【机构调研记录】工银瑞信基金调研海尔生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2636012675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636012675?lang=zh_cn&edition=full","pubTime":"2026-05-18 08:02","pubTimestamp":1779062533,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及5月15日披露的机构调研信息,工银瑞信基金近期对1家上市公司进行了调研,相关名单如下:1)海尔生物 调研纪要:2026年公司致力于实现员工持股计划中的收入目标,利润端有望迎来拐点。工银瑞信基金成立于2005年,截至目前,资产管理规模9317.54亿元,排名13/212;资产管理规模5068.12亿元,排名14/212;管理公募基金数504只,排名16/212;旗下公募基金经理86人,排名11/212。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800002698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412922","title":"每周股票复盘:海尔生物(688139)股东户数减少2.58%,持股集中度上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412922","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634412922?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:30","pubTimestamp":1778355032,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,海尔生物报收于31.83元,较上周的31.4元上涨1.37%。本周,海尔生物5月8日盘中最高价报32.21元。海尔生物当前最新总市值100.74亿元,在医疗器械板块市值排名34/129,在两市A股市值排名2098/5200。本周关注点股本股东变化:股东户数较前期减少2.58%,户均持股增至2.32万股股本股东变化:户均持股市值达72.78万元,较前期有所提升股本股东变化股东户数变动截至2026年4月30日,公司股东户数为1.37万户,较4月10日减少362.0户,减幅为2.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633173351","title":"股市必读:海尔生物(688139)股东户数1.37万户,较上期减少2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633173351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633173351?lang=zh_cn&edition=full","pubTime":"2026-05-08 03:05","pubTimestamp":1778180717,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘,海尔生物报收于31.62元,上涨0.19%,换手率0.64%,成交量2.03万手,成交额6391.6万元。交易信息汇总资金流向5月7日主力资金净流出581.13万元,占总成交额9.09%;游资资金净流入364.83万元,占总成交额5.71%;散户资金净流入216.31万元,占总成交额3.38%。股本股东变化股东户数变动近日海尔生物披露,截至2026年4月30日公司股东户数为1.37万户,较4月10日减少362.0户,减幅为2.58%。户均持股数量由上期的2.26万股增加至2.32万股,户均持股市值为72.78万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800002645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633928986","title":"股市必读:海尔生物(688139)股东户数1.4万户,较上期增加1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633928986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633928986?lang=zh_cn&edition=full","pubTime":"2026-05-06 02:34","pubTimestamp":1778006052,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,海尔生物报收于31.4元,下跌4.0%,换手率1.4%,成交量4.43万手,成交额1.41亿元。来自公司公告汇总:2026年第一季度营业收入同比下降5.36%,归属于上市公司股东的净利润同比下降27.93%。股本股东变化股东户数变动近日海尔生物披露,截至2026年4月10日公司股东户数为1.4万户,较3月31日增加204.0户,增幅为1.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600000790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632564464","title":"每周股票复盘:海尔生物(688139)股东户数增1.48%,Q1净利降27.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632564464","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632564464?lang=zh_cn&edition=full","pubTime":"2026-05-02 03:13","pubTimestamp":1777662789,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,海尔生物报收于31.4元,较上周的33.83元下跌7.18%。本周,海尔生物4月27日盘中最高价报33.95元。本周关注点股本股东变化:股东户数较3月31日增加204.0户,增幅为1.48%业绩披露要点:2026年第一季度归属于上市公司股东的净利润同比下降27.93%公司公告汇总:2026年第一季度营业收入为652,078,594.24元,同比下降5.36%股本股东变化截至2026年4月10日,公司股东户数为1.4万户,较3月31日增加204.0户,增幅为1.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631511111","title":"盈利加速改善!海尔生物一季报营收、归母净利润环比双增","url":"https://stock-news.laohu8.com/highlight/detail?id=2631511111","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631511111?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:31","pubTimestamp":1777465872,"startTime":"0","endTime":"0","summary":"4月29日晚,海尔生物披露2026年第一季度报告。数据显示,公司一季度实现营业收入6.52亿元,环比增长14.91%;归母净利润0.79亿元,环比大幅增长51.82%。毛利率较2025年全年提升0.76个百分点,归母净利润率较2025年全年提升1.42个百分点。海外市场一直是海尔生物价值增长主动力。综合来看,一季报数据的环比双增,叠加盈利能力的实质性改善、AI价值的有序兑现以及股东回报力度的持续加大,共同构成了海尔生物新一轮高质量增长的清晰图景。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026042900062067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628751331","title":"每周股票复盘:海尔生物(688139)股东户数增1.48%,户均持股市值70.84万","url":"https://stock-news.laohu8.com/highlight/detail?id=2628751331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628751331?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:33","pubTimestamp":1776540787,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,海尔生物报收于33.54元,较上周的31.37元上涨6.92%。本周关注点股本股东变化:股东户数较前期增加1.48%,户均持股市值为70.84万元公司公告汇总:2025年实现营收23.3亿元,海外收入同比增长17.9%公司公告汇总:员工持股计划获律所法律意见书支持,将提交股东大会审议股本股东变化截至2026年4月10日,公司股东户数为1.4万户,较3月31日增加204.0户,增幅1.48%。户均持股数量由上期的2.29万股下降至2.26万股,户均持股市值为70.84万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628869587","title":"海尔生物新注册《低温保存箱智能控制系统V1.0.0》等5个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2628869587","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628869587?lang=zh_cn&edition=full","pubTime":"2026-04-18 02:15","pubTimestamp":1776449713,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物新注册了5个项目的软件著作权,包括《低温保存箱智能控制系统V1.0.0》、《生物安全柜智能控制系统V1.0.0》、《医用低温冷藏冷冻智能控制系统V1.0.0》、《多通信物联设备数据智能控制系统V1.0.0》、《超低温深绿智能控制系统V1.0.0》等。今年以来海尔生物新注册软件著作权10个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800004436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","159180","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628078392","title":"海尔生物(688139)披露2026年员工持股计划(草案)法律意见书,4月17日股价下跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628078392","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628078392?lang=zh_cn&edition=full","pubTime":"2026-04-17 22:22","pubTimestamp":1776435742,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,海尔生物报收于33.54元,较前一交易日下跌1.44%,最新总市值为106.15亿元。该股当日开盘33.8元,最高33.92元,最低33.36元,成交额达1.19亿元,换手率为1.12%。公司已履行现阶段必要的内部审议程序和信息披露义务,尚需召开股东大会审议本次员工持股计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700046075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627296483","title":"海尔生物(688139)披露2025年年度股东会会议材料,4月16日股价上涨5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627296483","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627296483?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:39","pubTimestamp":1776332356,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘,海尔生物报收于34.03元,较前一交易日上涨5.0%,最新总市值为107.7亿元。该股当日开盘32.36元,最高34.22元,最低32.16元,成交额达2.26亿元,换手率为2.15%。公司于近日披露《海尔生物2025年年度股东会会议材料》。公告显示,青岛海尔生物医疗股份有限公司2025年度董事会工作报告指出,公司全年实现营业收入23.3亿元,同比增长2.0%,海外收入8.4亿元,同比增长17.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600032110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627614782","title":"海尔生物CMEF首秀AI自主实验室,打造生命科学的“AI底座”","url":"https://stock-news.laohu8.com/highlight/detail?id=2627614782","media":"财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627614782?lang=zh_cn&edition=full","pubTime":"2026-04-16 13:00","pubTimestamp":1776315600,"startTime":"0","endTime":"0","summary":"海尔生物联席CEO刘刚在现场宣布,公司将以AI+与多域场景的深度融合,构建“AI+自动化”能力,推进公司向全球引领的一体化生命科学工具与智能生产力平台迈进。AI加速落地生命科学场景:从“单点智能”到“系统智能”的跨越2025年财报披露显示,经过20年深耕,海尔生物已从单一低温存储厂商蜕变为覆盖低温存储、智慧用药、血液技术、实验室解决方案的综合性生命科学上游企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-16/doc-inhuskuk4053068.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-16/doc-inhuskuk4053068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGIX","CHAT","AIPO","LU2488822045.USD","ARTY","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627407141","title":"海尔生物(688139)4月10日股东户数1.4万户,较上期增加1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627407141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627407141?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:13","pubTimestamp":1776244393,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年4月10日公司股东户数为1.4万户,较3月31日增加204.0户,增幅为1.48%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至4月10日,医疗器械行业平均股东户数为2.19万户。从股价来看,2026年3月31日至2026年4月10日,海尔生物区间涨幅为0.51%,在此期间股东户数增加204.0户,增幅为1.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627172354","title":"东海证券:给予海尔生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627172354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627172354?lang=zh_cn&edition=full","pubTime":"2026-04-14 18:35","pubTimestamp":1776162921,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏近期对海尔生物进行研究并发布了研究报告《公司简评报告:海外业务增长良好,积极布局AI+创新业务》,给予海尔生物买入评级。 海尔生物 投资要点 收入端企稳,利润端继续承压。 风险提示:新业务拓展不及预期风险;海外业务拓展不及预期风险;市场竞争加剧风险等最新盈利预测明细如下:该股最近90天内共有3家机构给出评级,买入评级2家,增持评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400031050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627102880","title":"【机构调研记录】鑫元基金调研海尔生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2627102880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627102880?lang=zh_cn&edition=full","pubTime":"2026-04-13 08:02","pubTimestamp":1776038542,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及4月10日披露的机构调研信息,鑫元基金近期对1家上市公司进行了调研,相关名单如下:1)海尔生物 调研纪要:报告期内,公司I相关收入占整体收入比重达15%,较2024年提升2.5个百分点;全自动I细胞培养工作站实现细胞活率≥95%,生产效率提升150%以上;突破十万转超高速离心技术,稳定性提升30%,运维成本降低40%;并购业务收入贡献超30%,复合增长率30%;2025年第四季度扣非归母净利润实现正增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300001017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626151061","title":"智启科研新范式,海尔生物以“AI+”重塑中国生命科学产业未来","url":"https://stock-news.laohu8.com/highlight/detail?id=2626151061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626151061?lang=zh_cn&edition=full","pubTime":"2026-04-10 22:05","pubTimestamp":1775829955,"startTime":"0","endTime":"0","summary":"当前,中国生命科学产业正处AI变革的窗口期。未来,公司将如海尔生物联席CEO刘钢所提出的战略方向持续推进,以AI+与多域场景的深度融合,构建“AI+自动化”能力,向全球引领的一体化生命科学工具与智能生产力平台迈进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026041000040988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625118116","title":"每周股票复盘:海尔生物(688139)拟推2026年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2625118116","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625118116?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:44","pubTimestamp":1775331852,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,海尔生物报收于31.17元,较上周的30.65元上涨1.7%。本周关注点公司公告汇总:海尔生物拟实施2026年员工持股计划,已获职工代表大会审议通过。公司公告汇总青岛海尔生物医疗股份有限公司近日召开职工代表大会,审议通过《青岛海尔生物医疗股份有限公司2026年员工持股计划(草案)》及其摘要、《青岛海尔生物医疗股份有限公司2026年员工持股计划管理办法》。本次员工持股计划尚需提交公司股东会审议通过后方可实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624654539","title":"海尔生物(688139)披露2026年员工持股计划草案,4月3日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624654539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624654539?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:43","pubTimestamp":1775212991,"startTime":"0","endTime":"0","summary":"海尔生物于2026年4月3日发布《职工代表大会决议公告》。公告显示,公司近日召开职工代表大会,就拟实施的2026年员工持股计划征求职工代表意见。经与会职工代表民主讨论,审议通过了《青岛海尔生物医疗股份有限公司2026年员工持股计划(草案)》及其摘要和《青岛海尔生物医疗股份有限公司2026年员工持股计划管理办法》。本次员工持股计划尚需经公司股东会审议通过后方可实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622385270","title":"海尔生物(688139)2月28日股东户数1.39万户,较上期减少2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622385270","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622385270?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:04","pubTimestamp":1774688674,"startTime":"0","endTime":"0","summary":"证券之星消息,近日海尔生物披露,截至2026年2月28日公司股东户数为1.39万户,较1月31日减少309.0户,减幅为2.17%。在医疗器械行业个股中,海尔生物股东户数低于行业平均水平,截至2月28日,医疗器械行业平均股东户数为2.16万户。从股价来看,2026年1月31日至2026年2月28日,海尔生物区间跌幅为1.47%,在此期间股东户数减少309.0户,减幅为2.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621477682","title":"3月23日海尔生物跌5.52%,汇添富中证互联网医疗指数(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621477682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621477682?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:35","pubTimestamp":1774254922,"startTime":"0","endTime":"0","summary":"证券之星消息,3月23日海尔生物跌5.52%创60日新低,收盘报30.1元,换手率1.53%,成交量4.84万手,成交额1.48亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为汇添富基金的汇添富中证互联网医疗指数A。汇添富中证互联网医疗指数A目前规模为0.63亿元,最新净值0.928,较上一交易日下跌2.35%,近一年下跌6.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621796781","title":"每周股票复盘:海尔生物(688139)海外收入占比达36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796781","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796781?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:20","pubTimestamp":1774117223,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,海尔生物报收于31.86元,较上周的32.0元下跌0.44%。本周,海尔生物3月18日盘中最高价报33.89元。本周关注点来自机构调研要点:2025年海尔生物AI相关收入占比为15%。2025年海尔生物海外业务收入8.4亿元,同比增长17.9%,占公司主营收入比重达36%,较2024年提升5个百分点。公司公告汇总海尔生物将于2026年3月30日15:00-16:00通过上证路演中心召开2025年年度业绩说明会,介绍年度经营成果与财务状况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779162467669,"stockEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.019},{"period":"6month","weight":-0.0107},{"period":"1year","weight":0.078},{"period":"ytd","weight":0.0463}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0198},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0468},{"period":"1year","weight":0.2269},{"period":"ytd","weight":0.041}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"13724人(较上一季度增加0.51%)","perCapita":"23061股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":" 青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象,提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内,公司低温存储技术持续领先,依托制冷平台,通过持续优化制冷系统设计、温湿控制和节能技术等核心模块,在极致稳定、绿色效能方向上构筑起代际领先优势。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海尔生物,688139,海尔生物股票,海尔生物股票老虎,海尔生物股票老虎国际,海尔生物行情,海尔生物股票行情,海尔生物股价,海尔生物股市,海尔生物股票价格,海尔生物股票交易,海尔生物股票购买,海尔生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}